Yangchun Gu

Immune checkpoint inhibitor‐related adverse events in lung cancer: Real‐world incidence and management practices of 1905 patients in <scp>China</scp>

Yuequan Shi, Jian Fang, Chengzhi Zhou et al. · Thoracic Cancer · 2021 · 37 citations · Full text

Stepwise increase in the prevalence of isolated systolic hypertension with the stages of chronic kidney disease

Liqin Cheng, Yanhui Gao, Yangchun Gu et al. · Nephrology Dialysis Transplantation · 2008 · 29 citations

Real‐world data on EGFR/ALK gene status and first‐line targeted therapy rate in newly diagnosed advanced non‐small cell lung cancer patients in Northern China: A prospective observational study

Hongge Liang, Xia Song, Yuhui Zhang et al. · Thoracic Cancer · 2019 · 25 citations · Full text

Osimertinib versus comparator first-generation epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment in patients with advanced EGFR-mutated non-small cell lung cancer: a Chinese, multicenter, real-world cohort study

Dongming Zhang, Xiaoyan Liu, Fangfang Shen et al. · Translational Lung Cancer Research · 2023 · 18 citations · Full text

Value and significance of brain radiation therapy during first‐line <scp>EGFR‐TKI</scp> treatment in lung adenocarcinoma with <scp><i>EGFR</i></scp> sensitive mutation and synchronous brain metastasis: Appropriate timing and technique

Yangchun Gu, Yan Xu, Hongqing Zhuang et al. · Thoracic Cancer · 2021 · 15 citations · Full text